Bouas AP, Rheinheimer J, Lagopoulos J (2020) Why severe COVID-19 patients are at greater risk of developing depression: a molecular perspective
NIH/PMC research on GHK as a cellular pathway modulator describes how GHK-Cu induces systemic wound healing in rats, mice and pigs when injected at one site, improving healing at distant body areas, increasing collagen production, angiogenesis and wound closure parameters across both wound chambers and full thickness wounds
Research-use discussions usually describe 100-300 mcg per SubQ injection on an empty stomach, often three times daily and spaced at least 4 hours apart
Addressing zinc deficiency through dietary improvements and targeted supplementation could therefore play a critical role in maintaining immune resistance and reducing the impact of immunosenescence
GHK-Cu dosing in the glow stack In the standard 70mg glow stack vial, GHK-Cu makes up the largest portion at 50mg